Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pierson

Showing results (231-240 of 322) with videos related to

Pageof 33
Sort By:
Cell|March 25, 2017
Modified mRNA Vaccines Protect against Zika Virus InfectionJustin M Richner, Sunny Himansu, Kimberly A Dowd, et al.
Plos One|December 13, 2022
Association between cigarette smoking and ovarian reserve among women seeking fertility careIslamiat Oladipupo, T'shura Ali, David W Hein, et al.
Cell|February 23, 2017
Modified mRNA Vaccines Protect against Zika Virus InfectionJustin M Richner, Sunny Himansu, Kimberly A Dowd, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2010
Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasisLisa C Zaba, Judilyn Fuentes-Duculan, Narat John Eungdamrong, et al.
Journal of Virology|July 2, 2010
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2Soila Sukupolvi-Petty, S Kyle Austin, Michael Engle, et al.
Nature|July 8, 2016
A CRISPR screen defines a signal peptide processing pathway required by flavivirusesRong Zhang, Jonathan J Miner, Matthew J Gorman, et al.
The Journal of Investigative Dermatology|February 15, 2013
TREM-1 as a potential therapeutic target in psoriasisLuke A Hyder, Juana Gonzalez, Jamie L Harden, et al.
Nature Microbiology|November 21, 2018
A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virionsLeslie Goo, Kari Debbink, Nurgun Kose, et al.
Plos Pathogens|April 19, 2014
Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagementMelissa A Edeling, S Kyle Austin, Bimmi Shrestha, et al.
Frontiers in Neurology|October 30, 2025
Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case-control datasetBenjamin C Pierson, Megan Clare Craig-Kuhn, Laveta Stewart, et al.
Pageof 33

Showing results (231-240 of 322) with videos related to

Sort By:
Pageof 33
Cell|March 25, 2017
Modified mRNA Vaccines Protect against Zika Virus InfectionJustin M Richner, Sunny Himansu, Kimberly A Dowd, et al.
Plos One|December 13, 2022
Association between cigarette smoking and ovarian reserve among women seeking fertility careIslamiat Oladipupo, T'shura Ali, David W Hein, et al.
Cell|February 23, 2017
Modified mRNA Vaccines Protect against Zika Virus InfectionJustin M Richner, Sunny Himansu, Kimberly A Dowd, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2010
Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasisLisa C Zaba, Judilyn Fuentes-Duculan, Narat John Eungdamrong, et al.
Journal of Virology|July 2, 2010
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2Soila Sukupolvi-Petty, S Kyle Austin, Michael Engle, et al.
Nature|July 8, 2016
A CRISPR screen defines a signal peptide processing pathway required by flavivirusesRong Zhang, Jonathan J Miner, Matthew J Gorman, et al.
The Journal of Investigative Dermatology|February 15, 2013
TREM-1 as a potential therapeutic target in psoriasisLuke A Hyder, Juana Gonzalez, Jamie L Harden, et al.
Nature Microbiology|November 21, 2018
A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virionsLeslie Goo, Kari Debbink, Nurgun Kose, et al.
Plos Pathogens|April 19, 2014
Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagementMelissa A Edeling, S Kyle Austin, Bimmi Shrestha, et al.
Frontiers in Neurology|October 30, 2025
Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case-control datasetBenjamin C Pierson, Megan Clare Craig-Kuhn, Laveta Stewart, et al.
Pageof 33